🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Janssen-Cilag International NV — Licensed Medicines

98 medicines held by Janssen-Cilag International NV on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 98 products held by Janssen-Cilag International NV
MedicineActive substanceLicence holderStatus
STELARA 130 mg Concentrate for solution for infusion
EU/1/08/494/005
Ustekinumab Janssen-Cilag International NV
STELARA 45 mg Solution for injection
EU/1/08/494/003
Ustekinumab Janssen-Cilag International NV
STELARA 45 mg Solution for injection
EU/1/08/494/001
Ustekinumab Janssen-Cilag International NV
STELARA 90 mg Solution for injection
EU/1/08/494/004
Ustekinumab Janssen-Cilag International NV
Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets
EU/1/17/1225/001
Tenofovir alafenamide, Darunavir ethanolate, Emtricitabine, Cobicistat Janssen-Cilag International NV
TALVEY 2 mg/mL solution for injection
EU/1/23/1748/001
Talquetamab Janssen-Cilag International NV
TALVEY 40 mg/mL solution for injection
EU/1/23/1748/002
Talquetamab Janssen-Cilag International NV
TECVAYLI 10 mg/mL solution for injection
EU/1/22/1675/001
Teclistamab Janssen-Cilag International NV
TECVAYLI 90 mg/mL solution for injection
EU/1/22/1675/002
Teclistamab Janssen-Cilag International NV
Tracleer 125 mg film-coated tablets
EU/1/02/220/004
Bosentan Janssen-Cilag International NV
Tracleer 125 mg film-coated tablets
EU/1/02/220/005
Bosentan Janssen-Cilag International NV
Tracleer 32 mg dispersible tablets
EU/1/02/220/006
Bosentan Janssen-Cilag International NV
Tracleer 62.5 mg film-coated tablets
EU/1/02/220/001
Bosentan Janssen-Cilag International NV
Tracleer 62.5 mg film-coated tablets
EU/1/02/220/002
Bosentan Janssen-Cilag International NV
Tracleer 62.5 mg film-coated tablets
EU/1/02/220/003
Bosentan Janssen-Cilag International NV
Tremfya 100 mg Solution for injection pre-filled syringe
EU/1/17/1234/001
Guselkumab Janssen-Cilag International NV
Tremfya 200 mg Solution for injection pre-filled pen
EU/1/17/1234/008-009
Guselkumab Janssen-Cilag International NV
Tremfya 200 mg Solution for injection pre-filled syringe
EU/1/17/1234/006-007
Guselkumab Janssen-Cilag International NV
Trevicta 175mg Prolonged-release suspension for injection
EU/1/14/971/007
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Trevicta 263mg Prolonged-release suspension for injection
EU/1/14/971/008
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Trevicta 350mg Prolonged-release suspension for injection
EU/1/14/971/009
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Trevicta 525mg Prolonged-release suspension for injection
EU/1/14/971/010
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Uptravi 100 microgram film-coated tablets
EU/1/15/1083/012-013
Selexipag Janssen-Cilag International NV
Uptravi 1000 microgram film-coated tablets
EU/1/15/1083/007
Selexipag Janssen-Cilag International NV
Uptravi 1200 microgram film-coated tablets
EU/1/15/1083/008
Selexipag Janssen-Cilag International NV
Uptravi 1400 microgram film-coated tablets
EU/1/15/1083/009
Selexipag Janssen-Cilag International NV
Uptravi 1600 microgram film-coated tablets
EU/1/15/1083/010
Selexipag Janssen-Cilag International NV
Uptravi 200 microgram film-coated tablets
EU/1/15/1083/001-003
Selexipag Janssen-Cilag International NV
Uptravi 400 microgram film-coated tablets
EU/1/15/1083/004
Selexipag Janssen-Cilag International NV
Uptravi 600 microgram film-coated tablets
EU/1/15/1083/005
Selexipag Janssen-Cilag International NV
Uptravi 800 microgram film-coated tablets
EU/1/15/1083/006
Selexipag Janssen-Cilag International NV
Velcade 1 mg powder for solution for injection
EU/1/04/274/002
Ps-341 as boronic acid (bortezomib) Janssen-Cilag International NV
Velcade 3.5 mg powder for solution for injection
EU/1/04/274/001
Bortezomib Janssen-Cilag International NV
Veletri 0.5 Milligram Powder for Solution for Infusion
PA0885/001/001
EPOPROSTENOL SODIUM Janssen-Cilag International NV Marketed
Veletri 1.5 Milligram Powder for Solution for Infusion
PA0885/001/002
EPOPROSTENOL SODIUM Janssen-Cilag International NV Marketed
Vokanamet 150 mg/1000 mg Film-coated tablet
EU/1/14/918/010-012
Purified water, Hypromellose 2910, 15 mpa.s, Canagliflozin, Croscarmellose sodium, MICROCRYSTALLINE CELLULOSE Janssen-Cilag International NV
Vokanamet 150 mg/850 mg Film-coated tablet
EU/1/14/918/007-009
MICROCRYSTALLINE CELLULOSE, Croscarmellose sodium, Canagliflozin, Purified water, Metformin Hydrochloride Janssen-Cilag International NV
Vokanamet 50 mg/1000 mg Film-coated tablet
EU/1/14/918/004-006
Metformin Hydrochloride, MICROCRYSTALLINE CELLULOSE, Hypromellose 2910, 15 mpa.s, Purified water, Croscarmellose sodium Janssen-Cilag International NV
Vokanamet 50 mg/850 mg Film-coated tablet
EU/1/14/918/001-003
Metformin Hydrochloride, Purified water, Croscarmellose sodium, Hypromellose 2910, 15 mpa.s, MICROCRYSTALLINE CELLULOSE Janssen-Cilag International NV
Xeplion 100 mg prolonged-release suspension for injection
EU/1/11/672/004
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Xeplion 150 mg prolonged-release suspension for injection
EU/1/11/672/005
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Xeplion 150 mg prolonged-release suspension for injection Xeplion 100 mg prolonged-release suspension for injection
EU/1/11/672/006
Paliperidone, Paliperidone Janssen-Cilag International NV
Xeplion 25 mg prolonged-release suspension for injection
EU/1/11/672/001
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Xeplion 50 mg prolonged-release suspension for injection
EU/1/11/672/002
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Xeplion 75 mg prolonged-release suspension for injection
EU/1/11/672/003
Paliperidone palmitate (r092670) Janssen-Cilag International NV
Zavesca 100 mg capsules
EU/1/02/238/001
Miglustat Janssen-Cilag International NV
ZYTIGA 250 mg tablets
EU/1/11/714/001
Abiraterone acetate Janssen-Cilag International NV
ZYTIGA 500 mg tablets
EU/1/11/714/002-003
Abiraterone acetate Janssen-Cilag International NV
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.